Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
USDA Confirms Presence of New World Screwworm in the United States
Louisiana Department of Agriculture & Forestry
News By APHIS Press June 3, 2026 News article Animal Health Officials Working Quickly to Protect U.S. Livestock and Wildlife WASHINGTON, DC- JUNE 03, 2026 – The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service...
Chevalier du Grand Robert (CGR) Named #1 Bordeaux Wine Brand in the United States
EIN Presswire
The French brand's rise to #1 reflects a growing consumer preference for traditional winemaking, authenticity, and everyday value.
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
GlobeNewswire, Inc.
Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin’s proprietary position in non-invasive frequency-based deep-brain neurostimulation Patent covers transcranial...
Cultural Survival’s Indigenous Arts Bazaars Return to Rhode Island
EIN Presswire
RI, UNITED STATES, June 4, 2026 /EINPresswire.com/ -- Cultural Survival’s annual Indigenous Arts Bazaars, a flowing river of connection for Indigenous artists, activists, friends, and allies since 1975, are returning to Tiverton and Providence,...
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
GlobeNewswire, Inc.
Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitution Competitive Generic Therapy approval provides 180 days of market exclusivity and further expands Amneal’s differentiated...
Trump data confirms that Governor Newsom’s strategies have led to the largest reduction in homelessness nationwide
Office of the California Governor
California is leading the nation The new federal data published by the U.S. Department of Housing and Urban Development show California is making significant progress in reversing nearly every major category of homelessness: Largest reduction in...
Chairman Rick Scott Exposes How Overseas Drugs Harm Americans During Aging Committee Hearing
U.S. Senate Special Committee on Aging
WASHINGTON, D.C. — Today, Special Committee on Aging Chairman Rick Scott led a hearing titled “Poisoned Pills: The Human Cost of Dangerous Foreign Drugs” to highlight how substandard and contaminated drugs manufactured overseas, particularly in...
The Human Bean Celebrates America's 250th Birthday with Epic Summer Drink Lineup
GlobeNewswire, Inc.
Medford, OR, June 04, 2026 (GLOBE NEWSWIRE) -- The Human Bean is rolling out three brand-new drinks to celebrate the USA's 250th birthday.
Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis
GlobeNewswire, Inc.
NAPLES, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that the U.S. Food and Drug...
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
GlobeNewswire, Inc.
REYKJAVIK, Iceland, June 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
Alden's Organic Takes Taste Buds Around the World with New Global Delights Novelties
GlobeNewswire, Inc.
EUGENE, Ore., June 04, 2026 (GLOBE NEWSWIRE) -- Alden's Organic, the #1 organic ice cream brand in the U.S., is expanding its frozen novelties lineup with the launch of new Global Delights bars, featuring flavors Mango Chamoy Twist and Thai Tea...
Trending International Flavor Gochujang Leads Just Salad’s Summer 2026 Seasonal Menu
GlobeNewswire, Inc.
A Media Snippet accompanying this announcement is available by clicking on this link.
AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness
GlobeNewswire, Inc.
Video segment examines current Ebola outbreak concerns, unmet need surrounding the Bundibugyo strain and Ampligen’s previously published antiviral research Discussion highlights Ampligen’s immune-modulating mechanism, prior Biosafety Level 4...
Finley’s New Partnerships with Special Olympics and 2026 Special Olympics USA Games Support Athletes and Inclusion
EIN Presswire
"Treat with Kindness, Feed with Purpose" DELANO, MN, MN, UNITED STATES, June 4, 2026 /EINPresswire.com/ -- Finley’s, a brand renowned for its high-quality pet treats and commitment to empowering individuals across the ability spectrum, today...
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
GlobeNewswire, Inc.
-Designation provides regulatory and development incentives in Japan, including up to 10 years of market exclusivity upon approval- -Follows Orphan Drug Designation, Pediatric Rare Disease Designation, and Fast Track Designation previously granted...
TOMI Environmental Solutions, Inc. Scales Food Safety Presence with SteraMist Hybrid Installation at Expanded Food Facility
GlobeNewswire, Inc.
FREDERICK, Md., June 04, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced a signed purchase order for a custom SteraMist Hybrid system...
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
GlobeNewswire, Inc.
If approved, Joenja will be the first approved treatment in the U.S. for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Supplemental New Drug Application (sNDA) resubmission seeks...
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
GlobeNewswire, Inc.
NEW HAVEN, Conn., June 04, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced it has recently joined the LRRK2 Investigative...
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
GlobeNewswire, Inc.
Designation is supported by an exploratory analysis from the Phase 1b study showing that some children with SMA previously treated with gene therapy who had suboptimal clinical status experienced slowing of neurodegeneration and clinically...
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
GlobeNewswire, Inc.
IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use to achieve...
Sign up for:
American Food & Beverage Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.